Cost analysis of four strategies for prevention of CMV infection in liver transplant recipients

Transplant Proc. 1998 Aug;30(5):2102-3. doi: 10.1016/s0041-1345(98)00553-3.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Antiviral Agents / economics*
  • Antiviral Agents / therapeutic use
  • Costs and Cost Analysis
  • Cytomegalovirus Infections / economics
  • Cytomegalovirus Infections / prevention & control*
  • Drug Therapy, Combination
  • Ganciclovir / economics
  • Ganciclovir / therapeutic use
  • Humans
  • Immunization, Passive / economics*
  • Liver Transplantation / economics*
  • Postoperative Complications / prevention & control
  • United States

Substances

  • Antiviral Agents
  • Ganciclovir